USPTO Trademark Application Published for Opposition: CARDIODYN

ChangeBridge: Trademarks - Medical Services (Class 044)

Published March 25th, 2026

Detected March 26th, 2026

Summary

The USPTO has published the trademark application for 'CARDIODYN' for opposition. The application covers research and development services for medical devices, software for medical devices, and various implantable and extracorporeal heart support devices. The filing date was October 28, 2025.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application for 'CARDIODYN' (Application No. TM79443239) for a 30-day opposition period. The application seeks to register the mark for a broad range of goods and services related to cardiovascular medical devices, including research and development, software for medical devices, implantable and extracorporeal heart support systems, artificial heart pumps, and hemodynamic monitoring devices. The filing date for this application was October 28, 2025.

This publication signifies that the trademark has passed initial examination and is now open for third parties to oppose its registration. Companies operating in the medical device and cardiovascular health sectors should review the application details to determine if 'CARDIODYN' conflicts with their existing trademarks or business interests. The opposition period, which begins on the publication date of March 25, 2026, is a critical window for potential objectors to file a formal opposition with the USPTO.

What to do next

Review trademark application TM79443239 for potential conflicts.
Consider filing an opposition if conflicts are identified before the opposition period closes.

Source document (simplified)

← USPTO Trademark Applications

CARDIODYN

Published for Opposition TM79443239 Kind: published Mar 25, 2026

Abstract

Research and development services in the field of medical devices for assistance or supplementation of the heart; design, development, installation, maintenance and updating of software for medical devices; biomedical engineering services.; Implantable, invasive or external medical devices for assistance or supplementation of the heart, permanent or temporary; extracorporeal blood flow devices; ventricular assistance medical devices; extracorporeal blood circulation systems incorporating pressure sensors; artificial heart pumps; tanks, cannulas and tubes for extracorporeal blood circulation; on-board sensors for real-time detection of venous or arterial venous pressure; extracorporeal oxygenation systems; hemodynamic monitoring and control devices for patients of heart failure; membrane oxygenators integrated with blood circuits; extracorporeal circulation kits with thermal regulation; sensors for medical devices; connected blood pressure sensors; electronic apparatus for hemodynamic monitoring; computerized systems for regulating circulatory parameters; electronic systems for monitoring and controlling cardiac and circulatory functions.; Software for medical devices for assistance or supplementation of the heart; embedded software for steering cardiac medical devices; embedded software for real-time analysis of blood pressure data; software for controlling, monitoring and analyzing physiological data for medical devices; interface software for medical devices; secure programming interface software for therapeutic settings; secure control interface software for circulatory support devices; electronic sensors; embedded computer systems for medical devices; embedded biomedical data processing systems; mobile applications for monitoring patients with cardiac devices; mobile applications for remote monitoring of hemodynamic parameters; control software for mechanical heart pumps; interfaces software for ventricular assistance devices.; Services for remote monitoring of medical data for medical diagnostic and treatment purposes.